| Current Price | $2.21 | Mkt Cap | $109.1M |
|---|---|---|---|
| Open | $2.36 | P/E Ratio | 0.00 |
| Prev. Close | $2.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.21 - $2.38 | Volume | 257,556 |
| 52-Wk Range | $1.60 - $5.16 | Avg. Daily Vol. | 334,934 |
| Current Price | $2.21 | Mkt Cap | $109.1M |
|---|---|---|---|
| Open | $2.36 | P/E Ratio | 0.00 |
| Prev. Close | $2.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $2.21 - $2.38 | Volume | 257,556 |
| 52-Wk Range | $1.60 - $5.16 | Avg. Daily Vol. | 334,934 |
The best Bull and Bear pitches based on recency and number of recommendations.
I'm not going to bet against Auerbach. The successful lobbying for CHMP re-review is the latest example of his being able overcome naysayers. Given Nerlynx potential to win greater use and his past M&A exit with Cougar/JNJ, I'm thinking this one… More
Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.
Read the most recent pitches from players about PBYI.
Recs
TMFEBCapital
(76.92)
Submitted: 7/6/2018 3:45:30 PM :
Start Price:
$59.65
NASDAQ:PBYI Score:
-139.26
I'm not going to bet against Auerbach. The successful lobbying for CHMP re-review is the latest example of his being able overcome naysayers. Given Nerlynx potential to win greater use and his past M&A exit with Cougar/JNJ, I'm thinking this one makes sense to buy here.
Recs
foolsgold83
(< 20)
Submitted: 12/7/2017 12:57:33 AM :
Start Price:
$98.30
NASDAQ:PBYI Score:
-147.18
Prior success with leadership. Successfully bringing approved drugs to market. Will either continue to grow with successful trials or be acquired.
Recs
YourDailyBear
(45.54)
Submitted: 1/14/2016 1:28:07 PM :
Start Price:
$49.32
NASDAQ:PBYI Score:
+200.15
Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.
Find the members with the highest scoring picks in PBYI.
IBDContrarian (65.76) Score: +246.06
The Score Leader is the player with the highest score across all their picks in PBYI.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| IBDContrarian | 65.76 | 4/8/2013 |
|
5Y | $30.95 | -92.86% | +153.20% | +246.06 | 1 Comment | |
| kevrose31 | 78.84 | 1/10/2014 |
|
1Y | $110.14 | -97.99% | +113.72% | +211.71 | 0 Comment | |
| SimonSaysSell | 98.89 | 4/16/2014 |
|
NS | $73.01 | -96.97% | +111.97% | +208.94 | 0 Comment | |
| sobek1 | 73.63 | 8/6/2014 |
|
1Y | $230.97 | -99.04% | +105.71% | +204.76 | 0 Comment | |
| YourDailyBear | 45.54 | 1/14/2016 |
|
1Y | $49.32 | -95.52% | +104.63% | +200.15 | 1 Comment | |
| jayningpan | 64.98 | 8/18/2014 |
|
5Y | $262.01 | -99.16% | +99.36% | +198.52 | 0 Comment | |
| bumpyjr | 21.57 | 7/23/2014 |
|
5Y | $230.35 | -99.04% | +97.88% | +196.92 | 0 Comment | |
| jackbot | 96.56 | 7/24/2014 |
|
5Y | $214.06 | -98.97% | +97.87% | +196.83 | 0 Comment | |
| theMetz | 25.05 | 7/24/2014 |
|
1Y | $226.00 | -99.02% | +97.73% | +196.75 | 0 Comment | |
| newbie07 | 64.29 | 7/24/2014 |
|
5Y | $226.00 | -99.02% | +97.73% | +196.75 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
